ProfileGDS4718 / 204755_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 16% 23% 80% 16% 28% 17% 28% 22% 17% 14% 31% 20% 19% 29% 21% 15% 17% 14% 18% 11% 20% 19% 24% 27% 18% 30% 16% 16% 9% 23% 16% 39% 14% 9% 10% 47% 24% 14% 22% 88% 32% 17% 30% 9% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0211116
GSM549102patient 115, normal, homogenized [OPG study]4.2692323
GSM549104patient 119, normal, homogenized [OPG study]7.9838880
GSM549108patient 138, normal, homogenized [OPG study]4.0378816
GSM549119patient 077, normal, homogenized [OPG study]4.4680928
GSM549133patient 032, cancer, homogenized [OPG study]3.9906217
GSM549139patient 042, cancer, homogenized [OPG study]4.4296328
GSM549099patient 107, normal, homogenized [OPG study]4.2245822
GSM549109patient 139, normal, homogenized [OPG study]4.0492817
GSM549110patient 046, normal, homogenized [OPG study]3.9405314
GSM549114patient 063, normal, homogenized [OPG study]4.5555631
GSM549122patient 082, normal, homogenized [OPG study]4.1528220
GSM549134patient 033, cancer, homogenized [OPG study]4.0906119
GSM549136patient 036, cancer, homogenized [OPG study]4.4283229
GSM549140patient 044, cancer, homogenized [OPG study]4.1269521
GSM549111patient 047, normal, homogenized [OPG study]3.9451215
GSM549113patient 057, normal, homogenized [OPG study]4.0015117
GSM549132patient 031, cancer, homogenized [OPG study]3.9030114
GSM549137patient 038, cancer, homogenized [OPG study]4.0616918
GSM549142patient 047, cancer, homogenized [OPG study]3.8962911
GSM549100patient 110, normal, homogenized [OPG study]4.1712820
GSM549107patient 135, normal, homogenized [OPG study]4.0793419
GSM549115patient 068, normal, homogenized [OPG study]4.2316324
GSM549116patient 072, normal, homogenized [OPG study]4.3863327
GSM549120patient 078, normal, homogenized [OPG study]4.0519418
GSM549131patient 030, cancer, homogenized [OPG study]4.4725630
GSM549118patient 074, normal, homogenized [OPG study]4.0133516
GSM549129patient 027, cancer, homogenized [OPG study]3.9954416
GSM549123patient 088, normal, homogenized [OPG study]3.763029
GSM549124patient 006, cancer, homogenized [OPG study]4.2927623
GSM549126patient 015, cancer, homogenized [OPG study]3.9758116
GSM549128patient 025, cancer, homogenized [OPG study]4.9457239
GSM549103patient 117, normal, homogenized [OPG study]3.9467814
GSM549117patient 073, normal, homogenized [OPG study]3.753099
GSM549138patient 041, cancer, homogenized [OPG study]3.7738510
GSM549141patient 045, cancer, homogenized [OPG study]5.2974947
GSM549130patient 028, cancer, homogenized [OPG study]4.3081724
GSM549101patient 111, normal, homogenized [OPG study]3.9219914
GSM549105patient 128, normal, homogenized [OPG study]4.252122
GSM549106patient 134, normal, homogenized [OPG study]9.0771188
GSM549112patient 048, normal, homogenized [OPG study]4.6061432
GSM549125patient 011, cancer, homogenized [OPG study]4.0521217
GSM549127patient 024, cancer, homogenized [OPG study]4.5452330
GSM549135patient 035, cancer, homogenized [OPG study]3.700719